S.Amdt. 1149Senate118th Congress (2023-2025)
S.Amdt. 1149
Sponsored by
Sen. Marsha Blackburn (R-TN)
Submitted September 13, 2023
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
September 13, 2023
View full timeline
Floor
Senate amendment submitted
September 13, 2023
Floor
Senate amendment submitted
September 13, 2023
Text
Submitted
SA 1149. Mrs. BLACKBURN submitted an amendment intended to be proposed by her to the bill H.R. 4366, making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2024, and for other purposes; which was ordered to lie on the table; as follows: At the appropriate place in title VII of division B, insert the following: Sec. 7__. None of the funds made available to the Food and Drug Administration by this Act may be used to issue final guidance or a final rule that regulates laboratory-developed tests as devices (as defined in section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321)) until the date on which the Commissioner of Food and Drugs successfully completes a voluntary pilot certification program of excellence in vitro diagnostic validation under which the Commissioner shall certify developers of in vitro diagnostic tests if the developer meets criteria specified by the Commissioner regarding the ability of the developer to ensure the analytical and clinical validity of in vitro diagnostic tests for a designated scope of testing methodologies and techniques. ______